Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ba2c4156354c844d4a8883be561f00 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15042 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 |
filingDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fcee78f2f64382040f8a6bdd2998a2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c829cf0f7059ad7a6c1a2a93a87d3304 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4453046c0751f15146353b01798161d6 |
publicationDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017123688-A1 |
titleOfInvention |
A lentivirus packaging system comprising a synthetic positive feedback loop |
abstract |
Novel lentivirus packaging systems engineered with a synthetic gene network having a positive feedback loop to amplify the expression of virus genes are provided. When co-transfected into a host cell with a transfer plasmid and envelope vector, extremely high viral titers are achieved when compared to transfection of a host cell with conventional third generation packaging systems. Methods for enhancing production of lentivirus, compositions comprising high titer lentivirus, and therapeutic methods based on delivery of lentiviral nucleic acid to target cells are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113913460-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11767530-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11104902-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019060779-A1 |
priorityDate |
2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |